TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sanofi AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,539,846
|
1,338,172
|
1,128,844 |
| Financial expenses |
4,678
|
156
|
1,401 |
| Earnings before taxes |
69,975
|
38,048
|
54,887 |
| EBITDA |
70,955
|
38,669
|
56,212 |
| Total assets |
833,148
|
777,026
|
556,503 |
| Current assets |
826,861
|
769,495
|
549,195 |
| Current liabilities |
657,845
|
625,532
|
391,044 |
| Equity capital |
155,394
|
131,585
|
145,550 |
| - share capital |
2,630
|
2,630
|
2,630 |
| Employees (average) |
131
|
122
|
144 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.7%
|
16.9%
|
26.2% |
| Turnover per employee |
11,755
|
10,969
|
7,839 |
| Profit as a percentage of turnover |
4.5%
|
2.8%
|
4.9% |
| Return on assets (ROA) |
9.0%
|
4.9%
|
10.1% |
| Current ratio |
125.7%
|
123.0%
|
140.4% |
| Return on equity (ROE) |
45.0%
|
28.9%
|
37.7% |
| Change turnover |
201,674
|
209,328
|
-13,808 |
| Change turnover % |
15%
|
19%
|
-1% |
| Chg. No. of employees |
9
|
-22
|
-10 |
| Chg. No. of employees % |
7%
|
-15%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.